MedTrace Logo

Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)

NCT00574184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2017-10-31

No results posted yet for this study

Summary

The specific aim of this pilot study is to describe the angiographic prevalence and pattern of internal pudendal artery (and associated inflow vessel) atherosclerosis in patients with erectile dysfunction who are non-responsive to PDE-5 inhibitors (i.e., Viagra) who are referred for clinically-indicated cardiac catheterization.

Conditions

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Jason Rogers, MD · University of California, Davis

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2008-03-31
Completion
2008-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00574184 on ClinicalTrials.gov